Connect your AI

Aurinia Pharmaceuticals AUPH Shares (Basic)

Shares (Basic) at other companies

Rogers CorporationROG

17.8M-3.8%

Vera TherapeuticsVERA

71.5M+12.3%

ANI PharmaceuticalsANIP

20.9M+6.7%

Ultragenyx PharmaceuticalRARE

100.6M+4.5%

Agios PharmaceuticalsAGIO

58.8M+2.3%

Kiniksa Pharmaceuticals International, plcKNSA

76.5M+5.3%

Other financials

Income statement

Revenue$77.7M+24.4%

Gross profit$71.2M+32.1%

Operating income$41.4M+89.6%

Net income$34.4M+47.2%

EPS (diluted)$0.25+56.3%

Balance sheet

Cash & equivalents$41.0M-38.3%

Total debt$85.2M-7.9%

Total equity$567.6M+62.1%

Total assets$724.0M+43.4%

Cash flow

Operating cash flow$32.6M+2,405%

Valuation

Market cap$2.3B+78.5%

Enterprise value$2.34B+78.3%

P/E7.7×-24.6×

P/S7.7×+2.5×

Profitability

Gross margin89.7%+1.5pp

Operating margin41.7%+29.4pp

Net margin100%+83.9pp

Returns & leverage

Return on equity65%+53.8pp

Debt / equity0.2×-0.1×

Current ratio5.5×-0.4×

Where this comes from

Reported directly by Aurinia Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfSharesOutstandingBasic.

The official record: Aurinia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aurinia Pharmaceuticals's shares (basic).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Aurinia Pharmaceuticals's shares (basic)?: Aurinia Pharmaceuticals (AUPH) reported shares (basic) of 132.4M in Q1 2026.
How has Aurinia Pharmaceuticals's shares (basic) changed year-over-year?: Aurinia Pharmaceuticals's shares (basic) decreased by 4.7% year-over-year, from 138.9M to 132.4M.
What is the long-term trend for Aurinia Pharmaceuticals's shares (basic)?: Over 4 years (2021 to 2025), Aurinia Pharmaceuticals's shares (basic) has grown at a 1.3% compound annual growth rate (CAGR), from 513.4M to 540M.
What does shares (basic) mean?: The time-weighted average number of common shares outstanding during the period, used as the denominator for basic EPS calculations.